Product Information

LEVETIRACETAM 1,000 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $0.1667 per EA under NDC 67877077160. Its NADAC has been published 213 times since Oct 26, 2022.

FDA first approved this application on May 27, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LEVETIRACETAM 1,000 MG TABLET

Levetiracetam
$0.1667per EA

Strength

1000 mg/1

NDC

67877077160

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

LEVETIRACETAM

Approval Type

Generic (ANDA)

FDA Application

ANDA216375

FDA Approved

5/27/2022

TE Code

AB

On Market Since

5/28/2022

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for LEVETIRACETAM 1,000 MG TABLET has been published 213 times since Oct 26, 2022, and over the history we have for it it has declined 26.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1667 per EA
All-time high$0.2282 (Nov 16, 2022)
All-time low$0.1447 (Nov 20, 2024)
52-week high$0.1667
52-week low$0.1552
Median price$0.1689
Average price$0.1775
Largest weekly change+17.3% (Aug 21, 2024)
Weeks tracked213
Tracking sinceOct 26, 2022

Price History

1W

+1.4%

1M

+4.4%

3M

+6.5%

6M

+2.3%

1Y

+1.5%

3Y

-17.2%

5Y

N/A

All

-26.9%

Generic Alternatives

The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LEVETIRACETAM 1,000 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LEVETIRACETAM 1,000 MG TABLET, manufactured by Ascend Laboratories, LLC, is $0.1667 per EA (NDC 67877077160), effective Nov 18, 2026.

How has the price of LEVETIRACETAM 1,000 MG TABLET changed over time?

Over the history we have for it, the NADAC for LEVETIRACETAM 1,000 MG TABLET has declined 26.9%. It has been tracked across 213 weekly CMS publications since Oct 26, 2022.

What are the highest and lowest recorded NADAC prices for LEVETIRACETAM 1,000 MG TABLET?

Since Oct 26, 2022, the NADAC for LEVETIRACETAM 1,000 MG TABLET has ranged from a low of $0.1447 (Nov 20, 2024) to a high of $0.2282 (Nov 16, 2022), with a median of $0.1689 per EA.

Are there cheaper alternatives to LEVETIRACETAM 1,000 MG TABLET?

Yes. 14 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVETIRACETAM 1,000 MG TABLET, is $0.1624 per EA — about 3% below LEVETIRACETAM 1,000 MG TABLET.

Who manufactures LEVETIRACETAM 1,000 MG TABLET?

LEVETIRACETAM 1,000 MG TABLET (NDC 67877077160) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.